title: Kidney cancer: Intermittent sunitinib is an effective renal carcinoma treatment.
authors.affiliation: Military Institute of Medicine, Department of Oncology, Szaserow 128, 04-141 Warsaw, Poland.
authors.forename: Anna M
authors.initials: AM
authors.lastname: Czarnecka
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D000077210:Sunitinib / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000077210:Sunitinib